The company will look to offer a slew of new general unsecured senior notes in the funding round, according to the filing.
Medtronic said it plans to offer floating rate senior notes due 2021 alongside undisclosed percentage senior notes due 2021, 2023, 2027, 2031 and 2039, according to the SEC filings.
Amounts in the offering are preliminarily being offered in Euros, according to the filing.
Net proceeds from the offering are expected to support general corporate purposes, though the company said it has not determined the amount of net proceeds that will be used for any particular purpose at the medtech giant.
Last month, Medtronic announced a cash tender offer for up to $5 billion in outstanding debt, according to recently posted SEC filing.